This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Slama, G. Search for Related Content Social Bookmarking                         What's this?

The Diabetes Prevention Program: will it really change the way we manage glycaemia?

University Pierre et Marie CURIE, Paris, Hotel-Dieu Hospital, Paris, 1 Place du Parvis Notre Dame, 75004 Paris, France, gerard.slama{at}htd.ap-hop-paris.fr

Intervention in the pre-diabetic state to prevent diabetes, its complications and cardiovascular death provides an enticing therapeutic target. Although no drug treatments are as yet indicated for this condition, recent clinical evidence may support active intervention strategies to prevent the conversion of impaired glucose tolerance (IGT) to type 2 diabetes in the future. This article briefly reviews the current position in this field and considers the implications of findings from the latest clinical trials in subjects with IGT.

Key Words: metformin • impaired glucose tolerance • diabetes prevention • lifestyle intervention.

References

• DeFronzo RA Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 1997;50:191-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• UK Prospective Diabetes Study Group. UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995;44:1249-58.[Abstract]
• Köhler C., Temelkova-Kurktschiev T., Schaper F., Fücker K., Hanefeld M. Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes. Dtsch Med Wochenschr 1999;124:1057-61.[Medline] [Order article via Infotrieve]
• Heine RJ, Nijpels G., Mooy JM New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors. Diabet Med 1996;13(suppl 2):S12-4.[Web of Science][Medline] [Order article via Infotrieve]
• Saydah SH, Loria CM, Eberhardt MS, Brancati FL Subclinical states of glucose intolerance and risk of death in the US Diabetes Care 2001;24:447-53.[Abstract/Free Full Text]
• Saydah SH, Miret M., Sung J., Varas C., Gause D., Brancati FL Postchallenge hyperglycemia and mortality in a national sample of US adults. Diabetes Care 2001;24:1397-402.[Abstract/Free Full Text]
• O'Dea K. Westernization and non-insulin-dependent diabetes in Australian Aborigines. Ethn Dis 1991;1:171-87.[Medline] [Order article via Infotrieve]
• Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.[Abstract]
• Tuomilehto J., Lindstrom J., Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.[Abstract/Free Full Text]
• Wenying Y., Lixiang L., Jinwu Q., Guangwei L., Zhiqing Y., Xiaoren P. The preventive effect of acarbose and metformin on the IGT population from becoming diabetes mellitus: a 3 year multicentral prospective study. Chin J Endocrinol Metab 2001;17:131-4.
• Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.[Abstract/Free Full Text]
• Chiasson J-L., Josse RG, Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose can prevent the progression of impaired glucose tolerance to type 2 diabetes mellitus: results of a randomised clinical trial: the STOP-NIDDM trial. Lancet 2002;359:2072-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Stratton MI, Adler AI, Neil AW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.[Abstract/Free Full Text]
• American Diabetes Association, National Institute of Diabetes, Digestive and Kidney Diseases. Position statement: The prevention or delay of type 2 diabetes. Diabetes Care 2002;25:742-8.[Free Full Text]
• European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med 1999;16:716-30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Swinburn BA, Metcalf PA, Ley SJ Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 2001;24:619-24.[Abstract/Free Full Text]
• Wing ER, Venditti E., Polley BA, Lang W., Jakicic JM Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 1998;21:350-9.[Abstract]

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 4, 319-322 (2002)
DOI: 10.1177/14746514020020041801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Slama, G. Search for Related Content Social Bookmarking                         What's this?